Inari Begin Period Cash Flow from 2010 to 2024

NARI Stock  USD 43.96  0.15  0.34%   
Inari Medical's Begin Period Cash Flow is increasing with slightly volatile movements from year to year. Begin Period Cash Flow is predicted to flatten to about 58.7 M. Begin Period Cash Flow is the amount of cash Inari Medical has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2019-03-31
Previous Quarter
39.2 M
Current Value
67.2 M
Quarterly Volatility
52.6 M
 
Covid
Check Inari Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inari Medical's main balance sheet or income statement drivers, such as Net Interest Income of 16.2 M, Interest Income of 16.4 M or Depreciation And Amortization of 11.3 M, as well as many indicators such as Price To Sales Ratio of 7.09, Dividend Yield of 0.0 or PTB Ratio of 8.32. Inari financial statements analysis is a perfect complement when working with Inari Medical Valuation or Volatility modules.
  
Check out the analysis of Inari Medical Correlation against competitors.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

Latest Inari Medical's Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of Inari Medical over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Inari Medical's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inari Medical's overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Slightly volatile
   Begin Period Cash Flow   
       Timeline  

Inari Begin Period Cash Flow Regression Statistics

Arithmetic Mean28,877,161
Geometric Mean15,303,321
Coefficient Of Variation123.39
Mean Deviation28,106,537
Median6,771,000
Standard Deviation35,631,831
Sample Variance1269.6T
Range107.8M
R-Value0.73
Mean Square Error639.5T
R-Squared0.53
Significance0
Slope5,812,886
Total Sum of Squares17774.8T

Inari Begin Period Cash Flow History

202458.7 M
202360.2 M
202292.8 M
2021114.6 M
202024 M
201921.9 M

About Inari Medical Financial Statements

Investors use fundamental indicators, such as Inari Medical's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Inari Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Begin Period Cash Flow60.2 M58.7 M

Currently Active Assets on Macroaxis

When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:
Check out the analysis of Inari Medical Correlation against competitors.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(0.99)
Revenue Per Share
9.472
Quarterly Revenue Growth
0.225
Return On Assets
(0.02)
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.